Table 2. The univariate analysis of serum IL-33 level with the investigated parameters in the enrolled patients.
|
Parameters |
SCH group |
OH group |
||
|
r |
P value |
r |
P value |
|
|
Age (years) |
0.170 |
0.195 |
0.134 |
0.306 |
|
BMI (Kg/m2) |
0.113 |
0.389 |
0.177 |
0.0.020 |
|
T3(ng/mL) |
-0.230 |
0.047 |
-0.050 |
0.706 |
|
T4(ng/mL) |
-0.068 |
0.608 |
-0.145 |
0.042 |
|
TSH(µIU/mL) |
0.074 |
0.576 |
0.073 |
0.580 |
|
FSG (mg/dL) |
0.077 |
0.560 |
0.002 |
0.985 |
|
Insulin (µU/mL) |
0.007 |
0.958 |
0.287 |
0.026 |
|
HOMA-IR |
0.131 |
0.012 |
0.278 |
0.023 |
|
HOMA-β |
-0.063 |
0.633 |
-0.115 |
0.382 |
|
TG (mg/dl) |
0.367 |
0.004 |
0.031 |
0.814 |
|
TC (mg/dl) |
0.245 |
0.039 |
0.129 |
0.327 |
|
LDL-C (mg/dl) |
0.067 |
0.609 |
0.173 |
0.186 |
|
VLDL-C (mg/dl) |
0.367 |
0.004 |
0.031 |
0.814 |
|
HDL-C (mg/dl) |
0.004 |
0.977 |
-0.015 |
0.908 |
Here, p value =the significant difference between values in group (OH), group (SUB) and group (HC). Thyroxine (T4), triiodothyronine (T3) and thyroid stimulating hormone (TSH). SUB: subclinical hypothyroidism; OH: OVERT hypothyroidism; FSG: fasting serum glucose, HOMA-IR: hemostasis model assessment-insulin resistance, HOMA-β%: hemostasis model assessment-beta cell percentage, TG: triglyceride, HDL-C: High-density lipoprotein-cholesterol, LDL-C: low density lipoprotein-cholesterol VLDL.C: very low-density lipoprotein- Cholesterol, TC: total cholesterol, and r: linear regression.